|
Re: Share Liquidity
|
2
|
Zenith Epigenetics
|
Dec 17, 2017 03:06PM
|
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 14, 2017 06:21PM
|
|
CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 10, 2016 10:19AM
|
|
Re: While we wait, outside items that may be of interest
|
2
|
Resverlogix Corp.
|
Aug 27, 2017 11:11AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
2
|
Resverlogix Corp.
|
Dec 13, 2021 12:46PM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 17, 2019 01:33PM
|
|
Re: got this from Sarah yesterday..
|
2
|
Resverlogix Corp.
|
Mar 04, 2022 05:58PM
|
|
Re: Resverlogix & Zenith, hmmm...
|
2
|
Resverlogix Corp.
|
May 16, 2015 09:45AM
|
|
Re: Should I do a blog posting about Resverlogix?
|
2
|
Resverlogix Corp.
|
Apr 30, 2016 09:33AM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
2
|
Resverlogix Corp.
|
Jun 27, 2017 01:25PM
|
|
Re: Why have we not heard more about CURATE-AI?
|
2
|
Zenith Epigenetics
|
Mar 25, 2021 11:12AM
|
|
Re: Long Covid
|
2
|
Resverlogix Corp.
|
Jan 21, 2024 11:31AM
|
|
Re: Liquidity
|
2
|
Zenith Epigenetics
|
Aug 03, 2019 02:56PM
|
|
Re: Next Hurdle
|
2
|
Resverlogix Corp.
|
Jan 06, 2018 12:20PM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 06, 2018 02:51PM
|
|
Re: NEW BLOG POST
|
2
|
Resverlogix Corp.
|
Jun 18, 2015 08:27AM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Dec 10, 2015 08:35AM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 08, 2018 01:21PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 23, 2017 05:00PM
|
|
Re: RVX continuous good news
|
2
|
Resverlogix Corp.
|
Jun 04, 2015 11:27AM
|
